Horses are stoic animals. By the time a rider or owner notices that a horse is uncomfortable, the underlying issue has often been brewing for weeks or months. Musculoskeletal pain, chronic joint inflammation, and anxiety during transport are among the most common welfare concerns equine practitioners face. As hemp-derived cannabidiol (CBD) becomes more widely studied in companion animals, many horse owners are asking whether it has a role to play in equine care.

The short answer is: possibly — but the evidence base for horses is thinner than for dogs or cats, and several important caveats apply, particularly around competition use. This article covers what we know, what remains unknown, and what to look for if you decide to explore CBD for your horse.

Common Musculoskeletal and Behavioral Issues in Horses

Equine joint disease is extraordinarily common. Osteoarthritis (OA), particularly in the hocks, fetlocks, and coffin joints, affects a significant proportion of performance and pleasure horses alike. The condition is degenerative — cartilage breaks down over time, synovial fluid quality declines, and bone-on-bone contact causes persistent low-grade inflammation and pain that affects movement, willingness to work, and overall quality of life.

Laminitis — inflammation of the laminar tissue inside the hoof — can leave horses with chronic foot pain even after the acute episode resolves. These sequelae are often managed with NSAIDs like phenylbutazone ("bute"), but long-term NSAID use carries its own gastrointestinal and renal risks, prompting many owners to seek complementary options.

Beyond pain, anxiety is a significant issue. Trailer loading and transport stress triggers a measurable neuroendocrine response in horses: elevated cortisol, increased heart rate, and stereotypic behaviors like weaving or pawing. For horses that travel frequently to competitions or veterinary appointments, chronic transport stress is a real welfare concern.

The Endocannabinoid System in Horses

Like all mammals, horses possess an endocannabinoid system (ECS) — a network of receptors (CB1 and CB2), endogenous ligands (anandamide and 2-AG), and metabolic enzymes distributed throughout the body. CB1 receptors are concentrated in the central and peripheral nervous system, while CB2 receptors are more prevalent in immune tissues. Together, the ECS plays a modulatory role in pain perception, inflammation, immune response, and stress regulation.

CBD (cannabidiol) is a phytocannabinoid from the hemp plant (Cannabis sativa L.) that interacts with the ECS indirectly — it does not bind strongly to CB1 or CB2 receptors but influences them through several pathways, including inhibition of FAAH (the enzyme that breaks down anandamide) and action on TRPV1 pain receptors. It also has documented anti-inflammatory effects mediated through cytokine modulation.

Critically, horses have been confirmed to express cannabinoid receptors, meaning the theoretical mechanism for CBD's effects in equines exists. Whether the clinical effects seen in smaller animals translate to horses at practical doses is the key open question.

What the Research Actually Shows

Equine-specific CBD research remains sparse. The bulk of the cannabinoid science in veterinary medicine has been conducted in rodents, dogs, and cats. That said, a 2019 pharmacokinetic study (PMID 30020864) examined cannabinoid absorption in horses and found that oral administration produced detectable plasma levels, though bioavailability varied considerably between individuals — a finding consistent with what is observed in other species. A second study (PMID 32513210) reviewed cannabinoid use in veterinary species broadly and highlighted the anti-inflammatory and analgesic potential relevant to musculoskeletal conditions, while noting that dose-response data in large animals is lacking.

Anecdotally, equine practitioners who have experimented with CBD in their practices report observations of reduced stiffness, improved willingness to move, and calmer behavior during stressful events. These reports are encouraging but cannot substitute for controlled clinical trials.

The key takeaway from the current literature: the mechanistic rationale is sound, preliminary pharmacokinetic data is promising, but robust efficacy and safety data specific to horses is still missing. This should inform expectations and underscore the need for veterinary guidance.

Dosing Challenges in Large Animals

Dosing CBD for horses presents a unique practical challenge that does not exist with small animal patients. An average horse weighs 450–600 kg — roughly 10–15 times the weight of a large dog. Weight-based dosing extrapolated from canine studies would require substantial quantities of product, raising both cost and palatability concerns.

No standardized equine CBD dosing protocol has been established in peer-reviewed literature. Practitioners exploring this territory typically start conservatively — around 0.1–0.2 mg/kg of body weight — and titrate upward based on response, always under veterinary supervision. Products specifically formulated for equine use account for these quantities and are typically available in larger volumes or concentrated paste formats designed to be added to feed.

The form of administration matters: oil added to feed, pellets, or paste applied to the mouth all have different absorption profiles. Working with a veterinarian experienced in equine nutrition is essential to identify the most appropriate delivery format for your horse's needs and preferences.

Competition Rules: A Critical Caveat for Performance Horses

This is not a minor caveat. Hemp-derived CBD products with THC below 0.3% are legal in many jurisdictions, but "legal" and "competition-legal" are entirely different standards. The FEI's prohibited list is broader than national legal thresholds. Even trace amounts of cannabinoids can trigger a positive test depending on dose, individual metabolism, and the sensitivity of the assay used.

For pleasure horses or retirees with no competitive obligations, this concern is less pressing. For any horse competing under FEI or affiliated national federation rules, the risk is real and the consequences significant. Always consult both your veterinarian and the relevant governing body before use. Resources from the American Association of Equine Practitioners (AAEP) and the AVMA can help guide these conversations.

What to Look for When Buying Equine CBD

The equine supplement market is vast and minimally regulated. CBD products for horses vary enormously in quality, concentration, and transparency. When evaluating a product, prioritize the following:

• Third-party lab testing (Certificate of Analysis): Every batch should have an independent COA confirming cannabinoid content, confirming THC is below 0.3%, and screening for pesticides, heavy metals, and solvents.
• Clearly stated CBD concentration: You need to know how many milligrams of CBD per milliliter or gram of product to calculate a meaningful dose for a 500 kg animal.
• Formulation designed for horses: Not all animal CBD is interchangeable. Equine-specific formulations account for palatability, delivery format, and the volume needed for a horse's size.
• Manufacturer transparency: A reputable brand provides clear sourcing information, manufacturing standards, and is willing to answer detailed questions about their production process.
• Regulatory compliance: Products should be manufactured in compliance with relevant feedstuff or supplement regulations for the species.